| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Biazar, C., et al.
(författare)
-
Cutaneous lupus erythematosus : First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
- 2013
-
Ingår i: Autoimmunity Reviews. - : Elsevier BV. - 1568-9972 .- 1873-0183. ; 12:3, s. 444-454
-
Forskningsöversikt (refereegranskat)abstract
- In this prospective, cross-sectional, multicenter study, we assessed clinical and laboratory characteristics from patients with cutaneous lupus erythematosus (CLE) using the Core Set Questionnaire of the European Society of Cutaneous Lupus Erythematosus (EUSCLE). 1002 (768 females, 234 males) patients with different subtypes of CLE, such as acute CLE (ACLE, 304 patients), subacute CLE (SCLE, 236 patients), chronic CLE (CCLE, 397 patients), and intermittent CLE (ICLE, 65 patients), from 13 European countries were collected and statistically analyzed by an SPSS database. The main outcome measures included gender, age at onset of disease, LE-specific and LE-nonspecific skin lesions, photosensitivity, laboratory features, and the criteria of the American College of Rheumatology (ACR) for the classification of systemic lupus erythematosus. The mean age at onset of disease was 43.0±15.7 years and differed significantly between the CLE subtypes. In 347 (34.6%) of the 1002 patients, two or more CLE subtypes were diagnosed during the course of the disease and 453 (45.2%) presented with LE-nonspecific manifestations. Drug-induced CLE and SjögrenD́s Syndrome had the highest prevalence in SCLE patients (13.1% and 14.0%, respectively). Photosensitivity was significantly more frequent in patients with ACLE, SCLE, and ICLE compared with those with CCLE. The detection of antinuclear antibodies such as anti-Ro/SSA and anti-La/SSB antibodies revealed further significant differences between the CLE subtypes. In summary, the EUSCLE Core Set Questionnaire and its database facilitate the analysis of clinical and laboratory features in a high number of patients with CLE and will contribute to standardized assessment and monitoring of the disease in Europe.
|
|
| 6. |
- Blomstermo, Anders, et al.
(författare)
-
The perceived usefulness of network experiential knowledge in the internationalizing firm
- 2004
-
Ingår i: Journal of International Management. - : Elsevier. - 1075-4253 .- 1873-0620 .- 0813-0183. ; 10, s. 355-373
-
Tidskriftsartikel (refereegranskat)abstract
- Because networks are a growing mode of doing business, internationalizing firms need to understand how they can use experiential knowledge of networks. In the context of organizational learning theory, we discuss in this article the perceived usefulness of network experiential knowledge, its antecedents, and its performance effects in the internationalization process of firms. A LISREL analysis of 256 firms found that more perceived usefulness of network experiential knowledge has a performance enhancing effect. Preceding the perceived usefulness of network experiential knowledge is internationalization experiential knowledge. In-depth study of interaction effects found that firms that have diverse market experiences and that are in a new foreign expansion situation particularly find their network experiential knowledge useful. This implies that the internationalizing firm builds routines from diverse market experiences for the development of networks in the early stages of a specific new international business expansion.
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
- Damoiseaux, Jan, et al.
(författare)
-
Autoantibodies and SARS-CoV2 infection : The spectrum from association to clinical implication. Report of the 15th Dresden Symposium on Autoantibodies
- 2022
-
Ingår i: Autoimmunity Reviews. - : Elsevier. - 1568-9972 .- 1873-0183. ; 21:3
-
Forskningsöversikt (refereegranskat)abstract
- The relation between infections and autoimmune diseases has been extensively investigated. Multiple studies suggest a causal relation between these two entities with molecular mimicry, hyperstimulation and dysregulation of the immune system as plausible mechanisms. The recent pandemic with a new virus, i.e., SARS-CoV-2, has resulted in numerous studies addressing the potential of this virus to induce autoimmunity and, eventually, autoimmune disease. In addition, it has also revealed that pre-existing auto-immunity (auto-Abs neutralizing type I IFNs) could cause life-threatening disease. Therefore, the topic of the 15th Dresden Symposium on Autoantibodies was focused on autoimmunity in the SARS-CoV-2 era. This report is a collection and distillation of the topics presented at this meeting.
|
|
